Photodynamic therapy: New indications;Terapia fotodinámica: Nuevas indicaciones

Actas Dermo-Sifiliograficas

Volumn 98, Issue 6, 2007, Pages 377-395

  Fernández Guarino, Monserrat ^a   Garcia Morales I ^a   Harto, A ^a   Montull, C ^a   Perez Garcia B ^a   Jaen P ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Non melanoma skin cancer; Photodynamic therapy; Photosensitizers

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; CHLORMETHINE; CORTICOSTEROID; FLUOROURACIL; PHOTOSENSITIZING AGENT;

ACNE; ACTINIC KERATOSIS; ADJUVANT THERAPY; ALOPECIA AREATA; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BLISTER; BOWEN DISEASE; CANCER RADIOTHERAPY; CANDIDIASIS; CARBON DIOXIDE LASER; CLINICAL TRIAL; CONDYLOMA; CRYOTHERAPY; CUTANEOUS T CELL LYMPHOMA; EDEMA; ERYTHEMA; ERYTHROPLASIA; HIRSUTISM; HUMAN; HYPERPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KERATOACANTHOMA; LASER SURGERY; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; MELANOMA; MORPHEA; MYCOSIS; PAGET SKIN DISEASE; PAIN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PIGMENT DISORDER; PSORIASIS; PUVA; REVIEW; SCAR FORMATION; SEBORRHEA; SKIN CANCER; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; VASCULAR LESION; VERRUCA VULGARIS; WART VIRUS; XERODERMA PIGMENTOSUM;

ACNE VULGARIS; BOWEN'S DISEASE; DERMATITIS; FEMALE; HUMANS; MALE; PAIN; PATIENT DROPOUTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PSORIASIS; SKIN DISEASES; SKIN DISEASES, INFECTIOUS; SKIN NEOPLASMS;

EID: 34547860030     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(07)70471-7     Document Type: Review

References (123)

1. Morton CA, Brown SB, Collins S. Guidelines for topical photodynamic therapy: report of a workshop for the British Photodermatology Group. Br J Dermatol. 2002;146:552-7.
2. Taylor EL, Brown DB. The adventages of aminolevulinic acid photodynamic therapy in dermatology. J Dermatol Treat. 2002;13 Suppl 1:S3-11.
3. Gupta AK, Ryder J. Photodynamic therapy and topical aminolevulinic acid. An overview. Am J Clin Dermatol. 2003;4:699-708.
4. Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin Dermatol. 2006;24:16-25.
5. Uebelhoer N, Dover J. Photodynamic therapy for cosmetic applications. Dermatol Ther. 2005;18:242-52.
6. Gold M, Goldman M. 5-Aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol Surg. 2004;30:1077-84.
7. Boehncke WH, Koning K, Ruck A, Kaufmann R, Sterry W. In vitro and in vivo effects of photodynamic therapy in cutaneous T lymphoma. Acta Derm Venereol. 1994;74:201-5.
8. Boehncke WH, Ruck A, Naumann J, Sterry W, Kaufmann R. Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cells types in vitro. Lasers Surg Med. 1996;19:451-7.
9. Orenstein A, Haik J, Tamir J, Winkler E, Trau H, Malik Z, et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical aplication. Dermatol Surg. 2000;26:765-9.
10. Rittenhous-Diakun K, Van Leengoed H, Morgan J, Hryhorenko E, Paszkievicz G, Whitaker JE, et al. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem Photobiol. 1995;61:523-8.
11. Oseroff AR, Whitaker J, Conti C, et al. Effects of fluence and intensity in PDT cutaneous T-cell lymphoma with topical ALA: High intensity spares the epidermis. J Invest Dermatol. 1996;100;602.
12. Wang I, Bauer B, Anderson-Engels S. Photodynamic therapy utilizing delta aminolevulinic acid in non-melanoma skins malignancies of the eyelid and periocular skin. Acta Oftalm Scan. 1999;77:182-8.
13. Markham T, Sheehan K, Collins P. Topical 5-aminolvulinic acid photodynamic therapy for tumour-stage mycosis fungoides. Br J Dermatol. 2001;144:1262.
14. Edstrom DW, Portwit A, Ros AM. Photodynamic therapy with topical 5-aminolvulinic acid for mycosis fungoides: clinical and histological response. Acta Derm Venereol. 2001; 81:184-8.
15. Leman JA, Dick DC, Morton CA. Topical 5-ALA therapy for the treatment of cutaneous T-cell lymphoma. Clin Exp Dermatol. 2002;27:516-8.
16. Coors EA, von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2004;50:363-7.
17. Zane C, Venturini M, Sala R, Calzavara-Pinton P. Photodynamic therapy with mehtylaminolevulinate as a value treatment option for unilesional cutaneous T-cell lymphoma. Photodermatol Photoinmunol Photomed. 2006;22:254-8.
18. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol. 1998;13:207-14.
19. Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical delta aminolevulinic acid delays UV carcinogenesis in hairless mice. Photochem Photobiol. 1997;66:493-6.
20. Sharfaei S, Viau G, Lui H, Bouffard D, Bissonnette R. Systemic photodynamic therapy with aminolevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice. Br J Dermatol. 2001;144:1207-14.
21. De Graaf Y, Kennedy C, Wolterbeek R, Collen A, Willemze R, Bavink B. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: result of a randomized controlled trial. J Invest Dermatol. 2006;126:569-74.
22. Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation broad-area phtodynamic therapy for facial actinic keratosis and diffuse photodamage. Arch Dermatol. 2004;140: 33-40.
23. Piacquadio DJ, Chen DM, farber HF. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004;140:41-6.
24. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol. 2003;139;1313-20.
25. Bissonette R, Bergeron A, Liu Y. Large surface photodynamic therapy with aminolevulinc acid: treatment of actinic keratosis and beyond. J Drugs Dermatol. 2004;3:S26-S31.
26. Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol. 2004;3:S36-S9.
27. Goldman M. Terapia fotodinámica. 1.st ed. Editorial Elsevier; 2006.
28. Khan SA, Dougherty TJ, Mang TS. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur J Cancer. 1993;29A:1686-90.
29. Lapes M, Petera J, Jirsa M. Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)- porphin (TPPS4). J Photochem Photobiol B. 1996;36:205-7.
30. Henta T, Itoh Y, Kobayashi M, Ninomiya Y, Ishibashi A. Photodynamic therapy for inoperable vulval Paget's disease using delta-aminolaevulinic acid: successful management of a large skin lesion. Br J Dermatol. 1999;141:347-9.
31. Becker-Wegerich PM, Fritsch C, Schulte KW, Megahed M, Neuse W, Goerz G, et al. Carbon dioxide laser treatment of extramammary Paget's disease guided by photodynamic diagnosis. Br J Dermatol. 1998;138:169-72.
32. Berstein ZP, Wilson D, et al. Pilot study PDT for the treatment of AIDS-associated Kaposi sarcoma. Proc Soc Clin Oncol. 1994;13:51.
33. Hebeda KM, Huizing MT, Brouwer PA, van der Meulen FW, Hulseboch HJ, Reiss P, et al. Photodynamic therapy in AIDS-related cutaneous Kaposi sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 10:61-70.
34. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical 5-aminolaevulinic acid as an appropiate approach to the routine treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B. 1995;29:743-51.
35. Alster TL, Tanzi EL. Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol. 2003;2:501-4.
36. Mori M, Campoimi P, Mavilia L, Rossi R, Cappugi P, Pimpinelli N. Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study. J Am Acad Dermatol. 2006;54:524-6.
37. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, et al; International Society for Photodynamic Therapy in Dermatology. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;125-43.
38. Cox MH, Eedy DJ, Morton CA. Guidelines for management of Bowen's disease. Br J Dermatol. 1999;141:633-41.
39. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, et al. Photodynamic therapy of non-melanoma malignant tumour using topical delta-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol. 1994;130:743-51.
40. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with 5-aminolaevulinic acid for superficial primary and secundary skin cancer. Br J Cancer. 1994;69:605-8.
41. Morton CA, Whitehurst C, Moseley H, Mc Coll JH, Moore JV, Mackie RM. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996;135:766-71.
42. Stables GI, Stringer MR, Robinson DJ, Ash DV. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1997;136:957-60.
43. Stables GI, Stringer MR, Robinson DJ, Ash DV. The treatment of Bowen's disease by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1998;139 Suppl 51:74.
44. Varma S, Anstey A, Wilson H, et al. Photodynamic theray for the treatment of Bowen's disease, solar keratoses and superficial basal cell carcinoma: 12 months experience with a novel light source. Br J Dermatol. 1998;139 Suppl 51:19.
45. Morton CA, Whitehurst C, Moore JV, MacKie RM.Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol. 2000;143:767-72.
46. Morton CA, Whitehurst C, McColl JH, Moore JV, MacKie RM. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol. 2001;137:319-24.
47. Varma S, Wilson H, Kurwa HA, Gambles B, Charman C, Pearse AD, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144:567-74.
48. Wong TW, Sheu HM, Lee JY, Fletcher RJ. Photodynamic therapy for Bowen's disease (squamous cell carcinoma in situ) of the digit. Dermatol Surg. 2001;27:452-6.
49. Dijkstra AT, Majoie IM, van Dongen JW, van Weelden H, van Vloten WA. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J Eur Acad Dermatol. 2001;15:550-4.
50. Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol. 2003;148:539-43.
51. Dragieva G, Hafner J, Dummer R, Schmid-Grendelmeier P, Ross M, Prinz BM, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation. 2004;77:115-21.
52. Britton JE, Goulden V, Stables G, Stringer M, Sheehan-Dare R. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Br J Dermatol. 2005;153:780-4.
53. Baptista J, Martínez C, Leite L, Cochito M. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years. J Eur Acad Dermatol Venereol. 2006;20:693-7.
54. Stables GI, Stringer MR, Robinson DJ, Ash DV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1998;140:514-7.
55. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol. 2004;3:548-51.
56. Hauschild A, Lischner S, Lange-Asschenfeldt B, Egberts F. Treatment of actinic cheilitis using photodynamic therapy with methyl aminolevulinate: report of three cases. Dermatol Surg. 2005;31:1344-7.
57. Pollock B, Turner D, Stringer M. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004;151:616-22.
58. Bhardwaj S, Rohrer T, Arndt K. Lasers and light therapy for acne vulgaris. Semin Cutan Med Surg. 2005;24:107-12.
59. Charakida A, Seaton E, Charakida M. Phototherapy in the treatment of acne vulgaris. What is its role? Am J Clin Dermatol. 2004;5:211-6.
60. Papageorgiou P, Katsambas A, Chus A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142:973-8.
61. Zeina B, Greenman J, Purcel WM, Das B. Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol. 2001;144:274-8.
62. Hongcharu W. Topical ALA-Photodynamic Therapy for the Treatment of Acne Vulgaris. J Invest Dermatol. 2000;115:183-92.
63. Robinson DJ, Collins P, Stringer M, Vernon DI, Stables GI, Brown SB, et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol. 1999;79:451-5.
64. Kleinpenning MM, Smits TT, Ewalds E, van Erp P, van de Kerkhof P, Gerritsen M. Heterogeneity of fluorescence in psoriasis alter application of 5-aminolevulinic acid: an immunohistochemical study. Br J Dermatol. 2006;155:539-45.
65. Bissonette R, Tremblay JF, Jucenas P, Boushira M, Lui H. Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. J Invest Dermatol. 2002;119:77-83.
66. Boenhncke WH, Koning K, Haufmann, Scheffold W, Prummer O, Sterry W. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res. 1994;286:300-3.
67. Smits T, Kleinpenning MM, van Erp P, van de Kerkhof P, Gerritsen M. A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis. Br J Dermatol. 2006;155:429-36.
68. Fransson J, Ros AM. Clinical and inmunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed. 2005;21:326-32.
69. Weinstein G, Mc Cullough J, Jeffers E. Photodynamic therapy (PDT) on psoriasis with topical delta aminolevulinic acid (ALA): a pilot dose ranging study. Photoderm Photoinm Photobiol. 1994;10:92.
70. Collins P, Robinson DJ, Stringer MR, Stables GI, Sheehan-Dare RA.The variable response of plaque psoriasis after a single treatment with topical 5-aminolevulinic acid photodynamic therapy. Br J Dermatol. 1997;137:743-9.
71. Beattie PE, Dawe RS, Ferguson J, Ibbotson H. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clin Exp Dermatol. 2004;5:560.
72. Radakovic-Fijan S, Blecha-Thalhammer U, Scheleyer V, Szeimies RM, Zwingers T, Honigsmann H, et al. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol. 2005;152:279-83.
73. Schleyer V, Radakovic-Fijan S, Karrer S, Zwingers T, Landthaler M, Szeimies RM. Disapponting results and low tolerability of photodynamic therapy with topical 5-aminolaevulinic acid in psoriasis. A randomized, double-blind phase I/II study. J Eur Acad Dermatol. 2006;20:823-8.
74. Kim YJ, Kang HY, Lee ES, Kim YC. Topical 5-aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasis. J Dermatol. 2007;34:37-40.
75. Robinson DJ, de Bruijn HS, de Wolf WJ, Sterenborg HJ, Star WM. Topical 5-aminolevulinic acid -photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluoresecence kinetics, photobleaching and biological effects. Photochem Photobiol. 2000;72:794-802.
76. de Hass ER, Kruijt B, Sterenborg HJ, Martino Neumann HA, Robinson DJ. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J Invest Dermatol. 2006;126:2679-86.
77. Hillemanns P, Untch M, Prove F. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolaevulinic acid. Obstet Gynecol. 1999;93:71-4.
78. Karrer S, Abels C, Landthaler M, Szeimies RM. Topical photodymanic therapy for localized scleroderma. Acta Derm Venereol. 2000;80:26-7.
79. Monfrecola F, D'Anna F, Delfino M. Topical hematoporphyrin therapy plus UVA for the treatment of alopecia areata. Photodermatology. 1987;4:305-6.
80. Bissonette R, Shapiro J, Zeng H, McLean DI, Lui H. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata. Br J Dermatol. 2000;143:1032-5.
81. Kirby B, Whitehurst C, Moore JV. Treatment of lichen planus of the penis with PDT. Br J Dermatol. 1999;141:765-6.
82. Aghahosseine F, Arbabi-Kalati F, Ataie Fashtami L, Esmaeeli Djavid G, Fatech M. Methylene blue-mediated photodynamic therapy: A possible alternative treatment for oral lichen planus. Lasers Surg Med. 2006;38:33-8.
83. Karrer S, Abel C, Wimmershoff MB, Landthaler M, Szeimies RM, et al. Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. Arch Dermatol. 2002;138:581-4.
84. Babilas P, Karrer S, Sidoroff A, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology: an up to date. Photodermatol Photoinmunol Photomed. 2005;21:142-9.
85. Ruiz Rodríguez R, Álvarez JG, Laen P, Acevedo A, Córdoba S. Photodynamic therapy with 5-aminolevulinic acid for recalcitrant familial benign pemphigus (Hailey-Hailey disease). J Am Acad Dermatol. 2002;47:740-2.
86. Chiu LL, Sun CH, Yeh AT, Torkian B, Karamzadeh A, Tromberg B, et al. Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture. Lasers Surg Med. 2005;37:231-44.
87. Nayeemuddin FA, Wong M, Yell J, Rhodes LE. Topical photodynamic therapy in disseminated superficial actinic porokeratosis. Clin Exp Dermatol. 2002;27:703-6.
88. Takeda H, Kaneko T, Harada K, Matsusaki Y, Nakano H, Hanada K. Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid. Dermatology. 2005;211:264-6.
89. Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet. 2000;355:963-6.
90. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol. 2002;146:178-88.
91. Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, et al. Immunological and viral factors associated with the response of vulvar intraepithelial neoplasia to photodynamic therapy. Cancer Res. 2001;61:192-6.
92. Stender IM, Lock-Anderson J, Wulf HC. Recalcitrant hand and foot warts succesfully treated with photodynamic therapy with topical aminolaevulinic acid: a pilot study. Clin Exp Dermatol. 1999;24:154-9.
93. Fabbrocini G, Costanzo M, Riccardo A, et al. Photodynamic therapy with topical δ-aminolaevulinic acid for the treatment of plantar warts. J Photochem Photobiol B. 2001;61:30-4.
94. Stender IM, Borgbjerg FM, Villumsen J, Lock-Andersen J, Wulf HC. Pain induced by photodynamic therapy of warts. Photodermatol Photoinmunol Photomed. 2006;22:304-9.
95. Ross EV, Romero R, Kollias N, Crum C, Anderson RR. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Br J Dermatol. 1997;137:736-42.
96. Frank RG, Bos JD. Photodynamic therapy for condylomata acuminatawith local aplication of 5-aminolevulinic acid. Genitourn Med. 1996;72:70-1.
97. Fehr MK, Hornung R, Degen A, Schwarz VA, Fink D, Haller U, et al. Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg Med. 2002;30:273-9.
98. Stefanaki IM, Georgiou S, Themelis GC, Vazgiouraki EM, Tosca AD. In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata. Br J Dermatol. 2003;149:972-6.
99. Wang XL, Wang HW, Wang HS, Xu SZ, Liao KH, Hillemanns P. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol. 2004;151:880-5.
100. Herzinger T, Wienecke R, Weisenseel P, Borelli C, Berking C, Degitz K. Photodynamic therapy of genital condylomata in men. Clin Exp Dermatol. 2006;31:51-3.
101. Lobraico RV, Grossweiner LI. Clinical experiences with photodynamic therapy for recurrent malignancies of the lower female genital tract. J Gynecol Surg. 1993;9:29-34.
102. Karrer S, Szeimies RM, Abels C, Wlotzke U, Stolz W, Landthaler M. Epidermodysplasia verruciformis treated using topical 5-aminolevulinic acid photodynamic therapy. Br J Dermatol. 1999;140:935-8.
103. Bliss JM, Bigelow CE, Foster TH, Haidaris CG. Susceptibility of Candida species to photodynamic effects of photofrin. Antimicrob Agents Chemother. 2004;48: 2000-6.
104. Smijs TG, van der Haas RN, Lugtenburg J, Liu Y. Photodynamic treatment of the dermatophyte tricophyton rubrum and its microconidia with porphyrin photosensitizers. Photochem Photobiol. 2004;80:197-202.
105. Calzavara-Pinton PG, Venturini M, Sala R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B. 2005;78:1-6.
106. Kamp H, Tietz HJ, Lutz M, Piazena H, Sowyrda P, Lademann J, et al. Atifungal effec of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses. 2005; 48:101-7.
107. Calzavara-Pinton PG, Venturini M, Capezzera R, Sala R, Zane C. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Photodermatol Photoimmunol Photomed. 2004;20:144-7.
108. Gardlo K, Horska Z, Enk CD, Rauch L, Megahed M, Ruzicka T, et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol. 2003;48:893-6.
109. Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol. 2006;31:634-7.
110. Nestor MS, Gold MH, Kauvar AN. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol. 2006;5:140-54.
111. Nootheti PK, Goldman MP. Aminolevulinic acid-photodynamic therapy for photorejuvenation. Dermatol Clin. 2007;25:35-45.
112. Alster TS, Surin-Lord SS. Photodynamic therapy: practical cosmetic applications. J Drugs Dermatol. 2006;5:764-8.
113. Marmur ES, Phelps K, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther. 2005;7:21-4.
114. Evans AV, Robson A, Barlow RJ, Kurwa H. Treatment of port wine stains with photodynamic therapy, using pulsed dye laser as a light source, compared with pulsed dye laser alone: a pilot study. Lasers Surg Med. 2005;36:266-9.
115. Grossman M, Wimberly J, Dwyer P, et al. PDT for hirsutism. Lasers Surg Med. 1995;Supl 7:44.
116. Itoh Y, Ninomiya Y, Tajima S. Photodynamic therapy of acne vulgaris with topical δ-aminolevulinic acid and incoherent light in japanese patients. Br J Dermatol. 2001;144:575-9.
117. Arianee MA, Santos V, Belo VG. Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: comparative study. Dermatol Surg. 2005;31:910-5.
118. Wiegell S, Wulf H. Photodynamic therapy of acne vulgaris using 5-aminolevulnic acid versus methyl aminolevulinate. J Am Acad Dermatol. 2006;54:647-51.
119. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using methyl amonilevulinate: a blinded, randomized, controlled trial. Br J Dermatol. 2006;154:969-76.
120. Rojanamatin J, Choawawanich P. Treatment of inflammatory facial acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study. Dermatol Surg. 2006;32:991-7.
121. Yeung CK, Shek SY, Bjerring P. A comparative study of intense pulsed light alone and its combination with photodynamic therapy for treatment of facial acne in asian skin. Lasers Surg Med. 2007;39:1-6.
122. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg. 2006;32:795-801.
123. Ruiz-Rodríguez R, Sanz-Sánchez T, Córdoba S. Photodynamic photorejuvenation. Dermatol Surg. 2002;28:742-4.